Evofem Biosciences, Inc. (EVFM)
OTCMKTS: EVFM · Delayed Price · USD
0.0105
+0.0005 (5.00%)
Jul 19, 2024, 3:59 PM EDT - Market open
Evofem Biosciences Market Cap
Evofem Biosciences has a market cap or net worth of $651.63 thousand as of July 22, 2024. Its market cap has decreased by -99.28% in one year.
Market Cap
651.63K
Enterprise Value
42.37M
1-Year Change
-99.28%
Ranking
n/a
Category
Stock Price
$0.01
Market Cap Chart
Since November 20, 2014, Evofem Biosciences's market cap has decreased from $159.20M to $651.63K, a decrease of -99.59%. That is a compound annual growth rate of -50.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2022 | 6.10M | -90.05% |
| Dec 31, 2021 | 61.30M | -68.71% |
| Dec 31, 2020 | 195.90M | -32.17% |
| Dec 31, 2019 | 288.80M | 166.42% |
| Dec 31, 2018 | 108.40M | 301.48% |
| Dec 29, 2017 | 27.00M | 74.19% |
| Dec 30, 2016 | 15.50M | -18.85% |
| Dec 31, 2015 | 19.10M | -80.75% |
| Dec 31, 2014 | 99.20M | -37.69% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 814.94B |
| Novo Nordisk | 579.91B |
| UnitedHealth Group | 520.32B |
| Johnson & Johnson | 372.29B |
| Merck & Co. | 318.55B |
| AbbVie | 304.29B |
| AstraZeneca | 244.04B |
| Novartis AG | 207.64B |